Market Research Future

  Market Highlights Rabies is a life treating a viral disease which is caused by the biting of an infected rabid animal.  It is  fever, headache, muscle aches, loss of appetite, nausea, and tiredness to the infected animal or human. The surge in the prevalence of rabies, increasing awareness about rabies, and a rising number of pet animals are expected to drive the growth of the global rabies diagnostics market during the forecast period. Moreover, ongoing research and development activities by non-profit organizations and  aggressive strategies  by top players such as mergers, expansion, and collaboration for the development of new products and new product launches by major players are also boosting the growth of the market. According to the report published by World Organization for Animal Health, Asia-Pacific region is hugely affected by rabies owing to the increasing cases of rabies, in Asia approximately 31000 deaths were caused by rabies which is 56% of the total cases.  The  hig

  Market Highlights The  global inhalation anesthesia market  is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 1.12 billion in 2018 and is projected to register a CAGR of 3.8% over the forecast period. The  increasing cases of surgical procedures  and the growing older population are the key factors driving the inhalation anesthesia market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease, which eventually increases the cases of surgical procedures. Various other factors such as the advancements in  inhalation anesthesia,  increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing  surgical procedures are also expected to propel the growth of the market. However, the increasing concern about greenhouse gas emissions can hamper market growth o

  Market Highlights It is estimated that the global  gene expression analysis market  is expected to hold a market value of  USD 3,250 million  and register a  CAGR ~ 9.1%  during the forecast period of 2018–2023. Gene expression analysis is research dedicated towards functional genomics extending the application purview of studying genes and gene transcripts. Gene expression analysis is the method used for extraction of data from a gene which is used for the production of a practical gene product. The method can be used calculating the genetic code which is reserved in the DNA. This kind of research can be used for classifying diseases, which leads to a wide range of applications such as pharmacogenomics, diagnostics, biomarkers, and toxicology. Growing developments in personalized medicine and technological developments are driving market growth. According to a data published by the Foley & Lardner LLP, Food and Drug Administration (FDA) approved 16 new personalized medicines in

  Global Orphan Drugs Market - Overview The  global orphan drugs market  is growing exponentially owing to unmet needs for rare diseases and the growing investment in research and development are the major factor driving the orphan drugs Market. The global orphan drug market was estimated to be $93 billion in 2015 and is projected to reach $200 billion by 2022. Orphan drugs, represented 35% of the industry’s new drug approvals. The orphan drugs are disorders that affects a small percentage of the population. The major driving factor for the growth are low marketing cost, extensive exclusivity, government support leading to economic, legislative and tax benefits, new technology development such as hybridoma, gene mapping, and DNA recombinant. A pharmaceutical product aimed at rare diseases or disorders is known as an orphan drug. The Orphan Drug Act of 1983 has been financially incentivised through US law for the development of orphan drugs. According to the National Organization for Ra

  Market Highlights It is estimated that the  global healthcare predictive analytics market  is expected to register a CAGR ~29.3% during the forecast period of 2018–2023. The global healthcare predictive analytics market is expected to witness tremendous growth owing to the government initiatives to increase EHR adoption, growing venture capital investments, growing pressure to curb healthcare spending and improve patient outcomes. Other key factors such as rising healthcare costs; curb fraudulent claims, optimize provider networks, operational costs; increasing competition, the growing need to increase memberships are compelling healthcare payers to adopt analytics solutions. Get Free Sample PDF Brochure @   https://www.marketresearchfuture.com/sample_request/7549 However, factors such as lack of trained medical professionals is expected to curb the growth of the market during the forecast period. On the regional basis, the healthcare predictive analytics market in the Americas is pr

  Market Highlights The global leukemia therapeutics anticipated to have held a  Leukemia-Therapeutics-Market  value of USD 10.7 billion in the year 2017 and is expected to grow at a CAGR of 5.3% during the forecast period. Leukemia is blood cancer which most commonly in adults and children. Acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia are the major types of the leukemia. leukemia therapeutics such as chemotherapy, biological therapy, targeted therapy, radiation therapy, and stem cell transplant are used in treating the leukemia. Availability of innovative therapies for leukemia, increasing number of cases of leukemia, strong developing pipeline and targeted drug delivery, and increasing older population are expected to drive the growth of market. According to the Leukemia & Lymphoma Society of Canada, in 2016 estimated 22,510 were suffer with leukemia in Canada and 5,900 new cases of leukemia founded in same yea

  Market Highlights The  global cell surface markers market  is anticipated to hold a market value of USD 498 million in the year 2017 and is expected to grow at a CAGR of 8.4% during the forecast period. Cell surface markers or cell surface antigen work as monograms for identification and classification of cells. The proteins that are expressed on the cell surfaces often conveniently work as markers for specific types of cells. Increasing expenditure in the advancement of healthcare technology, advancement in technology, acquisitions by companies and outlook for reduction of costs associated with disease diagnosis are expected to drive the growth in the market over the forecast period. For instance, in April 2014, Beckman Coulter, acquired Xitogen Technologies, a cytometer manufacturer. This acquisition helped Beckman Coulter to broaden its product offerings and enabled business expansion in Asia.  However, complex products and expensive instruments & reagents can restrain the mar

  Market Highlights: The  Animal Genetics Market  is expected to witness tremendous growth owing to as increased adoption of genetic services to prevent genetic diseases and business loss, and rising acceptance of advanced genetic technologies. Other key factors such significant investments in R&D and expansions undertaken by key players are contributing towards the growth of the market. However, challenges such as need for specific breeding programs for breeds with inferior economic performance, and economic sustainability in local breeds is likely to curb the market growth during the forecast period. Get Free Sample PDF Brochure @   https://www.marketresearchfuture.com/sample_request/7004 Segmentation: The Global Animal Genetics Market is segmented into animal genetic products, services, and end-user. The Animal Genetics Market, by animal genetic products, the market is segmented into genetic materials and live animals. The live animals are further bifurcated into poultry, bovine

  Bioburden Testing Market - Highlights The  Global Bioburden Testing Market  is expected to register a CAGR of Approx. 9.15% during the forecast period of 2018–2023 with an estimated market value of USD 455 million. Bioburden testing refers to an estimation of microbial load on a medical instrument, raw material, packaged goods among others. Several factors such as rising medical spending, increasing food safety concerns and growing product recalls due to microbial contamination are projected to drive the growth of the market. On the other hand, high costs of microbial enumeration instruments and complex and time-consuming regulatory standards in some economies may curb the market growth during the assessment period. Moreover, test reports and certificates tend to be different from one country to another which hampers international trade. Therefore, in December 2017, International Organization for Standardization (ISO) published a new edition of ISO/IEC 17025 standard. This standard i

  Market Insights Nuclear Medicine is a branch of medicine which uses radioactive substances in small amounts for diagnosis and treatment of various diseases. Nuclear medicine can be used for the treatment of various conditions including blood disorder, and some cancers and use vastly different imaging technologies than those used in traditional imaging as they show physiological function of the particular system making it a more targeted method of imaging. Market Research Future's report on the  global nuclear medicine market  divulges a number of vital figures and facts about the market.  Nuclear Medicine Market  is projected to grow at a CAGR of 13% over the review period. With the rapid expansion of advanced medical technologies, the market is expected to grow at a consistent upward trend to approximate market value of USD 13 Bn by the end of 2027. Nuclear medicine offers precise diagnostic abilities and is useful in the early detection of cancer as well as other diseases such

  Market Highlights Global Veterinary Software Market  is expected to register a CAGR of  7.46 % during the forecast period, with a market value of USD 804.94 Million by 2027. Veterinary software is a system, which is used by veterinarians to manage the veterinary practice. The software is developed to improve the performance of veterinary practice through the easily accessed and well-organized computerized system. Diagnostic software gives access to lab technicians. Vets have all the information they need for monitoring the health of pigs or poultry. Inventory management software is used in hospitals & clinics to track the inventory, including sales tracking, stock level management, purchase order creation/tracking, and tracking margins, among others. The rise in companion animal ownership, growing prevalence of animal diseases, and rise in pet insurance with increasing animal health expenditure are expected to drive the growth of the global veterinary software market. However, la

  Market Highlights According to MRFR analysis,  Global Breast Lesion Localization Market  is expected to register a CAGR of 6.8% during the forecast period of 2019 to 2027 and is anticipated to reach  USD 560 Million by 2027. The growth of the global breast lesion localization market is driven by various factors, such as the increasing launch of breast lesion localization products and growing numbers of players involved in the development of new breast lesion localization technologies. Some of the key companies operating in this market are B.D. Company, Cook Medical, Endomagnetics Ltd, and others. In addition, the rising awareness program related to breast cancer supports the market growth during the forecasted period. However, the lack of skilled professionals and the cost of breast lesion localization products may hamper market growth. Get Free Sample PDF Brochure @   https://www.marketresearchfuture.com/sample_request/8785 Regional Analysis The market has been divided, by region, i

  Market Highlights Global Peripheral Artery Disease Market   is estimated to be valued at  USD 23,624.01 Million by 2025  and is expected to register a  CAGR of 4.84%  during the forecast period. Peripheral artery diseases (PAD) are the diseases of the blood vessels located outside the brain and heart. PAD occurs when plaque builds up in the arteries that carry blood to the head, organs, and limbs. Factors such as rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral artery diseases, along with increasing product approvals, are driving the growth of the peripheral artery disease market. Additionally, rising cases of diabetes are also driving the growth of the peripheral artery disease market. However, product recalls and failures are hampering the market growth. Get Free Sample PDF Brochure @   https://www.marketresearchfuture.com/sample_request/1540 Segment Analysis The Global Peripheral Artery Disease Market has been segmented on the ba